Two Sigma Securities’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
MMH
AFG
HIIFS
AS
NCM
CI
BCM
Two Sigma Securities's ELOX Position: Q1 2022 in Review
Two Sigma Securities sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2022, closing a stake of 437 shares — an estimated $12K sold.
Two Sigma Securities first reported a position in ELOX in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 35 funds tracked by Wall St. Rank hold ELOX as of Q1 2022.
- Two Sigma Securities reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Two Sigma Securities sold 437 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $12K.
- Two Sigma Securities first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
- Two Sigma Securities's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $12K in Q4 2021.
- 35 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2022.
Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.